Evidence map›Paper›PMID 41820630›Full record

SynthesisOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026

Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX.

John A Kanis, Eugene V McCloskey, Helena Johansson, Enwu Liu, Kristina E Åkesson, Fred A Anderson, Rafael Azagra-Ledesma, Cecilie L Bager, Charlotte Beaudart, Heike A Bischoff-Ferrari and 74 more

Erratum issuedAbstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

84 authors.

John A KanisCentre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. w.j.pontefract@sheffield.ac.uk.ORCID http://orcid.org/0000-0002-3129-4326
Eugene V McCloskeyCentre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-0177-8140
Helena JohanssonCentre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
Enwu LiuCollege of Medicine and Public Health, Flinders University, Adelaide, Australia.
Kristina E ÅkessonClinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0003-3024-2804
Fred A AndersonGLOW Coordinating Center, Center for Outcomes Research, University of Massachusetts Medical School, Worcester, MA, USA.
Rafael Azagra-LedesmaDepartment of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0093-333X
Cecilie L BagerNordic Bioscience A/S, Herlev, Denmark.
Charlotte BeaudartPublic Health Aging Research & Epidemiology (PHARE) Group, Research Unit in Clinical Pharmacology and Toxicology (URPC), NAmur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.ORCID http://orcid.org/0000-0002-0827-5303
Heike A Bischoff-FerrariDepartment of Geriatrics, University of Basel, Basel, Switzerland.
Emmanuel BiverDivision of Bone Diseases, Department of Medicine, Faculty of Medicine, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-6174-1951
Olivier BruyèrePublic Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.ORCID http://orcid.org/0000-0003-4269-9393
Jane A CauleyDepartment of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-0752-4408
Jacqueline R CenterGarvan Institute of Medical Research, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-5278-4527
Roland ChapurlatUMR 1033, INSERM, Université Claude Bernard-Lyon1, Hôpital Edouard Herriot, Lyon, France.
Claus ChristiansenNordic Bioscience A/S, Herlev, Denmark.
Cyrus CooperMRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0003-3510-0709
Carolyn J CrandallDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Steven R CummingsSan Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA, USA.
José A P da SilvaFaculty of Medicine, Coimbra Institute for Clinical and Biomedical Research, University of Coimbra, Coimbra, Portugal.
Bess Dawson-HughesJean Mayer Human Nutrition Research Center On Aging at Tufts University, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3136-0386
Adolfo Diez-PerezDepartment of Internal Medicine, Hospital del Mar and CIBERFES, Autonomous University of Barcelona, Barcelona, Spain.
Alyssa B DufourMarcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA, USA.
John A EismanSchool of Medicine and Health, Vincent's Clinical School, University of New South Wales Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-7162-7471
Petra J M Elders
Serge FerrariDivision of Bone Diseases, Department of Medicine, Faculty of Medicine, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
Yuki FujitaDepartment of Hygiene and Public Health, Faculty of Medicine, Kansai Medical University, Osaka, Japan.ORCID http://orcid.org/0000-0002-7490-258X
Saeko FujiwaraDepartment of Pharmacy, Yasuda Women's University, Hiroshima, Japan.
Claus-Christian GlüerSection Biomedical Imaging, Molecular Imaging North Competence Center, Department of Radiology and Neuroradiology, University Medical Center Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.
Inbal GoldshteinMaccabitech Institute of Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.ORCID http://orcid.org/0000-0002-5317-2848
David GoltzmanDepartment of Medicine, McGill University, McGill University Health Centre, Montreal, Canada.
Vilmundur GudnasonIcelandic Heart Association, Kopavogur, Iceland.
Jill HallMRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.
Didier HansCentre of Bone Diseases, Bone and Joint Department, Lausanne University Hospital, Lausanne, Switzerland.
Mari HoffDepartment of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.ORCID http://orcid.org/0000-0002-9992-8663
Rosemary J HollickAberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0001-6558-7189
Martijn HuismanDepartment of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Masayuki IkiDepartment of Hygiene and Public Health, Kansai Medical University, Hirakata, Osaka, Japan.
Sophia Ish-ShalomEndocrine Clinic, Einstein Clinic, Haifa, Israel.
Graeme JonesMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Magnus K KarlssonClinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0002-0616-5928
Sundeep KhoslaRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.
Douglas P KielDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Woon-Puay KohHealthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-5674-6341
Fjorda KoromaniDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Mark A KotowiczIMPACT (Institute for Mental and Physical Health and Clinical Translation), Deakin University, Geelong, VIC, Australia.ORCID http://orcid.org/0000-0002-8094-1411
Heikki KrögerDepartment of Orthopedics and Traumatology, Kuopio University Hospital, Kuopio, Finland.ORCID http://orcid.org/0000-0003-4245-8186
Timothy KwokDepartment of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.ORCID http://orcid.org/0000-0001-9253-3549
Olivier LamyCentre of Bone Diseases, Lausanne University Hospital, Lausanne, Switzerland.
Arnulf LanghammerDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, HUNT Research Centre, Norwegian University of Science and Technology, Trondheim, Norway.ORCID http://orcid.org/0000-0001-5296-6673
Bagher LarijaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kurt LippunerDepartment of Osteoporosis, Bern University Hospital, University of Bern, Bern, Switzerland.
Dan MellströmGeriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Thomas MerlijnDepartment of General Practice, UMC, Location AMC, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
Anna NordströmDivision of Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Peter NordströmUnit of Geriatric Medicine, Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden.
Terence W O NeillNational Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Barbara Obermayer-PietschDepartment of Internal Medicine, Division of Endocrinology and Diabetology, Medical University Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-3543-1807
Claes OhlssonDepartment of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Eric S OrwollDepartment of Medicine, Oregon Health and Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-8520-7355
Julie A PascoInstitute for Physical and Mental Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia.ORCID http://orcid.org/0000-0002-8968-4714
Fernando RivadeneiraDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Berit ScheiDepartment of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Anne-Marie SchottUniversité, U INSERM, Claude Bernard Lyon 11290 RESHAPE, Lyon, France.
Eric J ShiromaLaboratory of Epidemiology and Population Sciences, National Institute on Aging, Baltimore, MD, USA.
Kristin SiggeirsdottirIcelandic Heart Association, Kopavogur, Iceland.
Eleanor M SimonsickTranslational Gerontology Branch, National Institute On Aging Intramural Research Program, Baltimore, MD, USA.
Elisabeth Sornay-RenduUMR 1033, INSERM, University of Lyon, Hôpital Edouard Herriot, Lyon, France.
Reijo SundKuopio Musculoskeletal Research Unit, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0002-6268-8117
Karin SwartDepartment of General Practice, UMC, Location VUmc, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
Pawel SzulcPHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-4168-6697
Junko TamakiDepartment of Hygiene and Public Health, Faculty of Medicine, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka, Japan.
David J TorgersonYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Natasja M van SchoorDepartment of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0870-0795
Tjeerd P van StaaFaculty of Biology, Medicine and Health, School of Health Sciences, Centre for Health Informatics, University of Manchester, Manchester, UK.
Joan VilaStatistics Support Unit, Hospital del Mar Medical Research Institute, CIBER Epidemiology and Public Health (CIBERESP), Barcelona, Spain.
Nicholas J WarehamMRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
Nicole C WrightCenter for Health Outcomes, Implementation, and Community-Engaged Science, Deming Department of Medicine, Tulane University, New Orleans, LA, USA.ORCID http://orcid.org/0000-0001-8414-4842
Noriko YoshimuraDepartment of Preventive Medicine for Locomotive Organ Disorders, The University of Tokyo Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9206-4658
M Carola ZillikensDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Marta ZwartHealth Center Can Gibert del Pla, Catalan Institute of Health, Girona, Spain.ORCID http://orcid.org/0000-0003-4888-0927
Nicholas C HarveyMRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0002-8194-2512
Mattias LorentzonSahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
William D LeslieDepartment of Medicine, University of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0002-1056-1691

Funding

RISK FACTORS FOR VERTEBRAL FRACTURE AND BONE LOSSR01AR041398 · NIAMS · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI KIEL, DOUGLAS P. · 1991 to 2025
$16.1M
The Gut Microbiome and Bone MicroarchitectureR01AR061445 · NIAMS · HEBREW REHABILITATION CENTER FOR AGED · PI KIEL, DOUGLAS P. · 2012 to 2021
$8.9M
NIAMS NIH HHS R01 AR041398NIAMS NIH HHS R01 AR061445
6 · The paper itself

Abstract

The relationship between bone mineral density (BMD) at the femoral neck and fracture risk was determined in a meta-analysis of primary data of 307205 men and women from 53 cohort studies. Low BMD was an important predictor of fracture risk, particularly for hip fracture.

introductionThis study aimed to quantify the relationship between DXA-measured femoral neck BMD and fracture risk and examine the effect of age, sex, time since measurement, and initial BMD value on fracture risk, with a view to updating FRAX®.

methodsWe studied 307,205 men and women from within 53 predominately population-based cohorts followed up for an average of 8.7 years and a total of 2,683,185 person-years. The association of BMD and fracture risk was examined using a Poisson model in each cohort separately by sex. Results were expressed as a gradient of risk (GR, hazard ratio/standard deviation decrease in BMD). The different studies were then merged using weighted coefficients. 

resultsMost hip fractures arose in men and women with low bone mass or osteoporosis at baseline (73% and 92%, respectively) as was also the case for MOF (65% and 85%, respectively). BMD at the femoral neck strongly predicted hip fractures both in men and women with a similar gradient of risk and absolute risk at any given T-score. At the age of 65 years, the GR was 2.73 (95% CI = 2.29-3.26) in men and 2.61 (95% CI = 2.34-2.92) in women. However, the magnitude of association was significantly dependent on age, with a higher gradient of risk at younger ages. For example, at age 50 years, the GR was 3.49 (95% CI 2.51-4.84) in men and decreased to 2.14 (1.96-2.34) at age 80 years. The change in GR with age was slightly less marked in women (3.23 [2.75-3.80] and 2.11 [1.99-2.44], respectively). The GR for major osteoporotic fracture (MOF) remained unchanged with age (p = 0.12 for women and p = 0.89 for men). A significant decrease in GR for hip fracture was observed with increasing duration of follow-up, but the magnitude of the effect was modest compared with the effect of age. For other fracture outcomes, including non-hip major osteoporotic fracture, the gradient of risk was lower than for hip fracture.

conclusionsFemoral neck BMD is a risk factor for fracture of substantial importance, particularly for future hip fracture. The lower magnitude of association at older age is consistent with other non-skeletal factors contributing to hip fracture risk with advancing age. Its validation on an international basis supports its use in case finding strategies. Its use should, however, take account of the variations in predictive value of BMD with age, sex, length of follow-up, and BMD.

Indexed as

Bone DensityOsteoporotic FracturesAbsorptiometry, PhotonAgedAged, 80 and overFemaleFemur NeckHip FracturesHumansMaleMiddle AgedOsteoporosisPredictive Value of TestsRisk AssessmentBMDFRAXHip fractureMeta-analysisOsteoporotic fracture

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.